These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9410713

  • 1. [Is transcatheter occlusion of a persistent foramen ovale a possibility for the avoidance of a paradoxical embolism?].
    Berger F, Uhlemann F, Nürnberg JH, Haas NA, Lange PE.
    Dtsch Med Wochenschr; 1997 Nov 07; 122(45):1371-6. PubMed ID: 9410713
    [Abstract] [Full Text] [Related]

  • 2. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 07; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 3. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M.
    Catheter Cardiovasc Interv; 2007 Sep 07; 70(3):429-33. PubMed ID: 17722021
    [Abstract] [Full Text] [Related]

  • 4. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM, Amplatzer PFO Investigators.
    Catheter Cardiovasc Interv; 2003 Dec 07; 60(4):524-8. PubMed ID: 14624434
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
    Dubiel M, Bruch L, Liebner M, Schmehl I, Winkelmann A, Rux S, Sonntag S, Wulff H, Grad MO, Kleber FX.
    J Interv Cardiol; 2007 Aug 07; 20(4):275-81. PubMed ID: 17680857
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M, Casalino L, Gnecco G, Bezante GP, Pongiglione G, Marasini M, Del Sette M, Barsotti A.
    Am Heart J; 2008 Aug 07; 156(2):356-60. PubMed ID: 18657668
    [Abstract] [Full Text] [Related]

  • 9. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
    Zhang CJ, Huang YG, Huang XS, Huang T, Huang WH, Shen JJ, Xun ZR.
    Chin Med J (Engl); 2010 Apr 05; 123(7):834-7. PubMed ID: 20497673
    [Abstract] [Full Text] [Related]

  • 10. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B.
    Heart; 2008 Mar 05; 94(3):336-41. PubMed ID: 17639093
    [Abstract] [Full Text] [Related]

  • 11. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V, Reisman M, Fuller CJ, Spencer MP, Olsen JV, Krabill KA, Gray WA, Jesurum JT.
    Am J Cardiol; 2007 May 01; 99(9):1312-5. PubMed ID: 17478164
    [Abstract] [Full Text] [Related]

  • 12. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
    Rigatelli G, Giordan M, Braggion G, Aggio S, Chinaglia M, Zattoni L, Milan T, Cardaioli P.
    Cardiovasc Revasc Med; 2007 May 01; 8(4):248-50. PubMed ID: 18053946
    [Abstract] [Full Text] [Related]

  • 13. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
    Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH.
    Eur Heart J; 2004 Mar 01; 25(5):424-30. PubMed ID: 15033255
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
    Sievert H, Fischer E, Heinisch C, Majunke N, Roemer A, Wunderlich N.
    Circulation; 2007 Oct 09; 116(15):1701-6. PubMed ID: 17893276
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
    Bannan A, Shen R, Silvestry FE, Herrmann HC.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1066-9. PubMed ID: 19670302
    [Abstract] [Full Text] [Related]

  • 18. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.
    Am J Cardiol; 2008 May 15; 101(10):1487-92. PubMed ID: 18471463
    [Abstract] [Full Text] [Related]

  • 19. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI.
    Catheter Cardiovasc Interv; 2008 May 01; 71(6):822-8. PubMed ID: 18324695
    [Abstract] [Full Text] [Related]

  • 20. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
    Giardini A, Donti A, Formigari R, Bronzetti G, Prandstraller D, Bonvicini M, Palareti G, Guidetti D, Gaddi O, Picchio FM.
    Am J Cardiol; 2004 Oct 15; 94(8):1012-6. PubMed ID: 15476614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.